Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
|
|
Durata Therapeutics, Inc. (DRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/19/2014 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 11/19/2014 |
4
| Canaan VIII LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc. |
| 11/19/2014 |
4
| Ahrens Brenton Karl (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Unknown transaction of 1,902,030 shares
@ $0
Disposed/sold 5,034 shares
@ $0
Disposed/sold 1,216 options to buy
@ $0
Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
| 11/19/2014 |
4
| Canaan VIII LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Exercised 6,250 options to buy
@ $2.08, valued at
$13k
Exercised 1,216 restricted stock units
@ $0 |
|
| 11/19/2014 |
4
| Ahrens Brenton Karl (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Exercised 6,250 options to buy
@ $2.08, valued at
$13k
Exercised 1,216 restricted stock units
@ $0 |
|
| 11/19/2014 |
SC 13D/A
| Canaan VIII LP reports a 0% stake in DURATA THERAPEUTICS, INC. |
| 11/19/2014 |
SC 13D/A
| AISLING CAPITAL III LP reports a 0% stake in Durata Therapeutics, Inc. |
| 11/19/2014 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Durata Therapeutics, Inc. |
| 11/19/2014 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 11,145 options to buy
@ $7.16, valued at
$79.8k
Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
| 11/19/2014 |
SC 13D/A
| New Leaf Ventures II, L.P. reports a 0% stake in Durata Therapeutics, Inc. |
| 11/19/2014 |
4
| DE SCHUTTER RICHARD U (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 15,000 shares
@ $0
Disposed/sold 12,500 shares
@ $0
Disposed/sold 4,375 options to buy
@ $10, valued at
$43.8k
Disposed/sold 1,250 options to buy
@ $7.16, valued at
$9k
Disposed/sold 1,876 options to buy
@ $7.16, valued at
$13.4k
Disposed/sold 14,489 options to buy
@ $7.16, valued at
$103.7k
Disposed/sold 10,290 options to buy
@ $16.15, valued at
$166.2k
|
|
| 11/18/2014 |
4
| OBOYLE KEVIN C (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 5,000 shares
@ $0
Disposed/sold 6,250 options to buy
@ $10, valued at
$62.5k
Disposed/sold 1,875 options to buy
@ $10, valued at
$18.8k
Disposed/sold 1,875 options to buy
@ $7.16, valued at
$13.4k
Disposed/sold 2,813 options to buy
@ $7.16, valued at
$20.1k
Disposed/sold 11,145 options to buy
@ $7.16, valued at
$79.8k
Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
| 11/18/2014 |
4
| Fishman Corey N. (CFO&COO) has filed a Form 4 on Durata Therapeutics, Inc. |
| 11/18/2014 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 8,134 options to buy
@ $16.77, valued at
$136.4k
|
|
| 11/18/2014 |
4
| YARNO WENDY L (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 8,134 options to buy
@ $16.77, valued at
$136.4k
|
|
| 11/18/2014 |
4
| Shannon John Patrick Jr (Chief Commercial Officer) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 11,000 shares
@ $0
Disposed/sold 93,750 options to buy
@ $2.08, valued at
$195k
Disposed/sold 20,000 options to buy
@ $7.49, valued at
$149.8k
Disposed/sold 75,000 options to buy
@ $16.15, valued at
$1.2M
|
|
| 11/18/2014 |
4
| Edick Paul R (CEO) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 45,636 shares
@ $0
Disposed/sold 500 shares
@ $0
Disposed/sold 656,250 options to buy
@ $0.96, valued at
$630k
Disposed/sold 42,234 options to buy
@ $10, valued at
$422.3k
Disposed/sold 12,500 options to buy
@ $10, valued at
$125k
Disposed/sold 100,000 options to buy
@ $7.49, valued at
$749k
Disposed/sold 300,000 options to buy
@ $16.15, valued at
$4.8M
|
|
| 11/18/2014 |
4
| Dunne Michael W. (Chief Medical Officer) has filed a Form 4 on Durata Therapeutics, Inc. |
| 11/18/2014 |
4
| New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 3,028,439 shares
@ $0 |
|
| 11/18/2014 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 3,006,132 shares
@ $0 |
|
| 11/18/2014 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 22,306 shares
@ $0 |
|
| 11/18/2014 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 6,250 shares
@ $0 |
|
| 11/18/2014 |
4
| VITULLO NICOLE (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
| 11/17/2014 |
8-K
| Quarterly results |
| 11/17/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/17/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/13/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/07/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 11/04/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/31/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/31/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/24/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/24/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/17/2014 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
|
|
|